Guest: TJ Gan, MD, MBA, MHS, FRCA (UK), FRCA (lre), LicAc

Guest: Dru Riddle, PhD, DNP, CRNA

When it comes to postoperative nausea and vomiting (PONV) management, multimodal, antiemetic therapy based on patients’ risk factors is routinely provided to minimize the incidence, but unfortunately, patients may still develop breakthrough PONV, in which an antiemetic should be administered from a different class from what's given for prevention.1 Barhemsys® (amisulpride) is an FDA-approved antiemetic for the treatment of PONV in patients who have or have not received prophylaxis.2 Learn more about this treatment option along with current management guidelines, key clinical considerations, and a real-world case study with TJ Gan, MD, MBA, MHS, and Dru Riddle, PhD, DNP. Dr. Gan is the Head of the Division of Anesthesiology and Perioperative Medicine, Critical Care, and Pain Medicine at the University of Texas MD Anderson Cancer Center in Houston, and Dr. Riddle is a certified nurse anesthetist at Texas Christian University in Ft. Worth, TX.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Henry Rosenberg, MD

Malignant hyperthermia is an inherited disorder primarily recognized by anesthesia professionals. And since this condition can have significant consequences on a patient’s health, including their likelihood of surviving surgery, it’s important to know how to diagnose and treat malignant hyperthermia emergencies in operating room settings. Join Dr. Charles Turck as he dives deeper into this topic with Dr. Henry Rosenberg, a member of the Board of Directors of the Malignant Hyperthermia Association of the United States.

Host: Jacob Sands, MD

Guest: Daniel Sessler, MD

Our choice of anesthesia, whether it's regional or general, can have an effect on the outcome of our patients. But can this decision also contribute to cancer recurrence? To understand this, Dr. Jacob Sands sits down with renowned researcher in the anesthesia community, Dr. Dan Sessler, to learn more about his research on the impacts of general anesthesia.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Emily Carroll, JD, MSW

The No Surprises Act aims to protect consumers from surprise medical bills. But how exactly does it go about doing that, and what’s the current status of its implementation? Joining Dr. Charles Turck to share progress and challenges associated with the No Surprises Act is Ms. Emily Carroll, a senior legislative attorney for the American Medical Association's Advocacy Resource Center.

Host: Linda Bernstein, Pharm.D.

A sedative commonly used in anesthesia, dexmedetomidine hydrochloride has been the subject of many news reports over the past few months. But most recently, the FDA announced approval for Aurobindo Pharma’s dexmedetomidine hydrochloride in 0.9% sodium chloride injection. In this episode of The Drug Report, Dr. Linda Bernstein reviews recent approvals of dexmedetomidine hydrochloride on initially intubated and mechanically ventilated patients.

Published December 17, 2020

Host: Matt Birnholz, MD

Guest: Wes Ely, MD, MPH

After surviving a critical illness, many patients look forward to their lives returning to normal, but unfortunately, that’s not always possible.

To uncover the far-reaching impacts of delirium, Dr. Matt Birnholz is joined by Dr. Wes Ely, Professor of Medicine and Co-Director of the Center for Critical Illness, Brain Dysfunction and Survivorship Center at Vanderbilt University’s School of Medicine which focuses on improving the lives and care of patients in the intensive care unit to ensure both physical and cognitive rehabilitation.

The Gender, Sexuality and HIV Prevention Center at Ann & Robert H Lurie Children's Hospital of Chicago is the first of its kind facilty for adolescent patients. Host Dr. Jennifer Caudle welcoms the center's director, Dr. Robert Garofalo. Dr. Garofalo will share the center's mission of supporting multidisciplinary academic subjects including sexual health, gender, sexuality, HIV prevention and health disparities which affect adolescent and young adult populations at risk of acquiring HIV. The Center partners with similar organizations throughout the country in creating an environment where clinicians, academics and scientists can collaborate to design projects with public health significance.

Robert Garofalo, MD, MPH, is Professor of Pediatrics and Preventive Medicine at Northwestern University Feinberg School of Medicine. He is also an Attending Physician at Lurie Children's, where he directs the Adolescent/Young Adult HIV Program. Dr. Garofalo is a national authority on LGBT health issues, adolescent sexuality, and HIV clinical care and prevention.

Host: Lauren Streicher, MD

Guest: Susan Love, MD

Dr. Susan Love, medical director and founder of the Dr. Susan Love Research Foundation, joins host Dr. Lauren Streicher to talk about the Love/Avon Army of Women initiative, which seeks to recruit one million women of all ages and backgrounds to participate in breast cancer research. Dr. Love explains how doctors can apply to be involved in the research process and how your patients can become part of the army of women.

Host: Shira Johnson, MD

Guest: Calvin A. Brown III, MD

Once the sole domain of anesthesiologists, rapid sequence intubation is now a skill practiced by all emergency department physicians. Dr. Calvin Brown III, attending physician in the emergency department at Brigham and Woman's Hospital in Boston, explains the state of the art in intubation. Dr. Brown is interviewed by Dr. Shira Johnson as he reviews the basic technique of RSI, some of the pearls and pitfalls, and what is on the horizon for this skilled intubation technique.

Host: Jay Goldstein, MD

Guest: Douglas Rex, MD

Gastroenterology-directed propofol is controversial among many practitioners, even though evidence suggests it is very safe. What barriers are there to gastroenterologists administering propofol, without an anesthesiologist on site? Guest Dr. Douglas Rex, Chancellor's Professor and professor of medicine at Indiana University School of Medicine, and host Dr. Jay Goldstein examine the reasons for the slow growth of gastroenterologist-directed propofol, and what the future of anesthesiology might be for gastroenterologists.